Product NDC: | 0591-3636 |
Proprietary Name: | Trospium Chloride |
Non Proprietary Name: | Trospium Chloride |
Active Ingredient(s): | 60 mg/1 & nbsp; Trospium Chloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0591-3636 |
Labeler Name: | Watson Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091289 |
Marketing Category: | ANDA |
Start Marketing Date: | 20121012 |
Package NDC: | 0591-3636-05 |
Package Description: | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0591-3636-05) |
NDC Code | 0591-3636-05 |
Proprietary Name | Trospium Chloride |
Package Description | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0591-3636-05) |
Product NDC | 0591-3636 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Trospium Chloride |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20121012 |
Marketing Category Name | ANDA |
Labeler Name | Watson Laboratories, Inc. |
Substance Name | TROSPIUM CHLORIDE |
Strength Number | 60 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |